- Report
- April 2024
- 132 Pages
Global
From €3559EUR$3,950USD£3,052GBP
- Report
- September 2024
- 150 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- June 2023
- 95 Pages
North America
From €1352EUR$1,500USD£1,159GBP
- Report
- September 2025
- 99 Pages
Global
From €3500EUR$4,161USD£3,106GBP
The Generic Injectable market is a segment of the drug delivery industry that focuses on the production and distribution of generic injectable drugs. These drugs are typically administered via injection and are used to treat a variety of medical conditions. Generic injectables are typically cheaper than their branded counterparts, making them a popular choice for patients and healthcare providers alike.
Generic injectables are typically produced in bulk and then packaged and distributed to pharmacies and hospitals. The production process involves the use of sterile manufacturing techniques and quality control measures to ensure the safety and efficacy of the drugs.
Generic injectables are an important part of the drug delivery industry, as they provide an affordable and effective way to treat a variety of medical conditions.
Some companies in the Generic Injectable market include Hospira, Mylan, Teva Pharmaceuticals, Sandoz, and Fresenius Kabi. Show Less Read more